Koninklijke Philips N.V.
Koninklijke Philips N.V. RYLPF Peers
See (RYLPF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RYLPF | $23.85 | +0.01% | 22.8B | 77.42 | $0.31 | +3.96% |
| SMMNY | $26.83 | +0.56% | 119.7B | 24.26 | $1.10 | +1.11% |
| SEMHF | $54.03 | -1.76% | 60.6B | 24.78 | $2.18 | +1.83% |
| SONVY | $58.48 | +0.09% | 17.3B | 25.24 | $2.29 | +1.09% |
| SONVF | $284.75 | -3.04% | 17B | 25.02 | $11.38 | +1.84% |
| SNNUF | $14.75 | +1.03% | 13.1B | 31.91 | $0.47 | +2.50% |
| CHEOY | $99.85 | -0.64% | 13.1B | 53.64 | $1.86 | +1.40% |
| CHEOF | $193.04 | -7.06% | 12.6B | 52.03 | $3.71 | +1.44% |
| WILYY | $20.19 | +0.00% | 9.2B | 20.49 | $1.05 | N/A |
| WILLF | $42.17 | +1.01% | 8.6B | 19.88 | $2.10 | N/A |
Stock Comparison
RYLPF vs SMMNY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, SMMNY has a market cap of 119.7B. Regarding current trading prices, RYLPF is priced at $23.85, while SMMNY trades at $26.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas SMMNY's P/E ratio is 24.26. In terms of profitability, RYLPF's ROE is +0.03%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, RYLPF is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SEMHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, SEMHF has a market cap of 60.6B. Regarding current trading prices, RYLPF is priced at $23.85, while SEMHF trades at $54.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas SEMHF's P/E ratio is 24.78. In terms of profitability, RYLPF's ROE is +0.03%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, RYLPF is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SONVY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, SONVY has a market cap of 17.3B. Regarding current trading prices, RYLPF is priced at $23.85, while SONVY trades at $58.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas SONVY's P/E ratio is 25.24. In terms of profitability, RYLPF's ROE is +0.03%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, RYLPF is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SONVF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, SONVF has a market cap of 17B. Regarding current trading prices, RYLPF is priced at $23.85, while SONVF trades at $284.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas SONVF's P/E ratio is 25.02. In terms of profitability, RYLPF's ROE is +0.03%, compared to SONVF's ROE of +0.22%. Regarding short-term risk, RYLPF is less volatile compared to SONVF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SNNUF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, SNNUF has a market cap of 13.1B. Regarding current trading prices, RYLPF is priced at $23.85, while SNNUF trades at $14.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas SNNUF's P/E ratio is 31.91. In terms of profitability, RYLPF's ROE is +0.03%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, RYLPF and SNNUF have similar daily volatility (0.00).
RYLPF vs CHEOY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, CHEOY has a market cap of 13.1B. Regarding current trading prices, RYLPF is priced at $23.85, while CHEOY trades at $99.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas CHEOY's P/E ratio is 53.64. In terms of profitability, RYLPF's ROE is +0.03%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, RYLPF and CHEOY have similar daily volatility (0.00).
RYLPF vs CHEOF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, CHEOF has a market cap of 12.6B. Regarding current trading prices, RYLPF is priced at $23.85, while CHEOF trades at $193.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas CHEOF's P/E ratio is 52.03. In terms of profitability, RYLPF's ROE is +0.03%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, RYLPF and CHEOF have similar daily volatility (0.00).
RYLPF vs WILYY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, WILYY has a market cap of 9.2B. Regarding current trading prices, RYLPF is priced at $23.85, while WILYY trades at $20.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas WILYY's P/E ratio is 20.49. In terms of profitability, RYLPF's ROE is +0.03%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, RYLPF and WILYY have similar daily volatility (0.00).
RYLPF vs WILLF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, WILLF has a market cap of 8.6B. Regarding current trading prices, RYLPF is priced at $23.85, while WILLF trades at $42.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas WILLF's P/E ratio is 19.88. In terms of profitability, RYLPF's ROE is +0.03%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, RYLPF and WILLF have similar daily volatility (0.00).
RYLPF vs GNGBY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, GNGBY has a market cap of 5.4B. Regarding current trading prices, RYLPF is priced at $23.85, while GNGBY trades at $19.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas GNGBY's P/E ratio is 35.04. In terms of profitability, RYLPF's ROE is +0.03%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, RYLPF and GNGBY have similar daily volatility (0.00).
RYLPF vs GNGBF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, GNGBF has a market cap of 5.1B. Regarding current trading prices, RYLPF is priced at $23.85, while GNGBF trades at $21.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas GNGBF's P/E ratio is 36.11. In terms of profitability, RYLPF's ROE is +0.03%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, RYLPF and GNGBF have similar daily volatility (0.00).
RYLPF vs AMBBY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, AMBBY has a market cap of 4.1B. Regarding current trading prices, RYLPF is priced at $23.85, while AMBBY trades at $15.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas AMBBY's P/E ratio is 69.32. In terms of profitability, RYLPF's ROE is +0.03%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, RYLPF and AMBBY have similar daily volatility (0.00).
RYLPF vs AMBFF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, AMBFF has a market cap of 3.9B. Regarding current trading prices, RYLPF is priced at $23.85, while AMBFF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas AMBFF's P/E ratio is 66.82. In terms of profitability, RYLPF's ROE is +0.03%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, RYLPF and AMBFF have similar daily volatility (0.00).
RYLPF vs NHNKY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, NHNKY has a market cap of 3.7B. Regarding current trading prices, RYLPF is priced at $23.85, while NHNKY trades at $12.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas NHNKY's P/E ratio is 19.12. In terms of profitability, RYLPF's ROE is +0.03%, compared to NHNKY's ROE of +0.08%. Regarding short-term risk, RYLPF is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs NHNKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, NHNKF has a market cap of 2.5B. Regarding current trading prices, RYLPF is priced at $23.85, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, RYLPF's ROE is +0.03%, compared to NHNKF's ROE of +0.08%. Regarding short-term risk, RYLPF and NHNKF have similar daily volatility (0.00).
RYLPF vs MCRPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, MCRPF has a market cap of 2.3B. Regarding current trading prices, RYLPF is priced at $23.85, while MCRPF trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas MCRPF's P/E ratio is -10.17. In terms of profitability, RYLPF's ROE is +0.03%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, RYLPF and MCRPF have similar daily volatility (0.00).
RYLPF vs GNNDY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, GNNDY has a market cap of 2.3B. Regarding current trading prices, RYLPF is priced at $23.85, while GNNDY trades at $46.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas GNNDY's P/E ratio is 17.70. In terms of profitability, RYLPF's ROE is +0.03%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, RYLPF is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs OSSFF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, OSSFF has a market cap of 2.2B. Regarding current trading prices, RYLPF is priced at $23.85, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas OSSFF's P/E ratio is 30.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, RYLPF and OSSFF have similar daily volatility (0.00).
RYLPF vs STSEY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, STSEY has a market cap of 2B. Regarding current trading prices, RYLPF is priced at $23.85, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas STSEY's P/E ratio is 39.41. In terms of profitability, RYLPF's ROE is +0.03%, compared to STSEY's ROE of +0.07%. Regarding short-term risk, RYLPF and STSEY have similar daily volatility (0.00).
RYLPF vs VTRLY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, VTRLY has a market cap of 2B. Regarding current trading prices, RYLPF is priced at $23.85, while VTRLY trades at $14.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas VTRLY's P/E ratio is 43.82. In terms of profitability, RYLPF's ROE is +0.03%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, RYLPF and VTRLY have similar daily volatility (0.00).
RYLPF vs GGNDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, GGNDF has a market cap of 1.8B. Regarding current trading prices, RYLPF is priced at $23.85, while GGNDF trades at $14.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas GGNDF's P/E ratio is 14.26. In terms of profitability, RYLPF's ROE is +0.03%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, RYLPF and GGNDF have similar daily volatility (0.00).
RYLPF vs DWRKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, RYLPF is priced at $23.85, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, RYLPF's ROE is +0.03%, compared to DWRKF's ROE of N/A. Regarding short-term risk, RYLPF and DWRKF have similar daily volatility (0.00).
RYLPF vs OSSUY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, RYLPF is priced at $23.85, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, RYLPF's ROE is +0.03%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, RYLPF and OSSUY have similar daily volatility (0.00).
RYLPF vs MEDGF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, RYLPF is priced at $23.85, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, RYLPF's ROE is +0.03%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, RYLPF and MEDGF have similar daily volatility (0.00).
RYLPF vs DRWKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, DRWKF has a market cap of 1.4B. Regarding current trading prices, RYLPF is priced at $23.85, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas DRWKF's P/E ratio is 9.71. In terms of profitability, RYLPF's ROE is +0.03%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, RYLPF and DRWKF have similar daily volatility (0.00).
RYLPF vs MDRSF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, MDRSF has a market cap of 1.3B. Regarding current trading prices, RYLPF is priced at $23.85, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas MDRSF's P/E ratio is 300.03. In terms of profitability, RYLPF's ROE is +0.03%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, RYLPF and MDRSF have similar daily volatility (0.00).
RYLPF vs IMEXF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, IMEXF has a market cap of 1.2B. Regarding current trading prices, RYLPF is priced at $23.85, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas IMEXF's P/E ratio is -0.17. In terms of profitability, RYLPF's ROE is +0.03%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, RYLPF and IMEXF have similar daily volatility (0.00).
RYLPF vs DGWPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, DGWPF has a market cap of 1.1B. Regarding current trading prices, RYLPF is priced at $23.85, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas DGWPF's P/E ratio is 7.84. In terms of profitability, RYLPF's ROE is +0.03%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, RYLPF and DGWPF have similar daily volatility (0.00).
RYLPF vs LFTSF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, LFTSF has a market cap of 858.1M. Regarding current trading prices, RYLPF is priced at $23.85, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas LFTSF's P/E ratio is 19.50. In terms of profitability, RYLPF's ROE is +0.03%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, RYLPF and LFTSF have similar daily volatility (0.00).
RYLPF vs ELEAF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, ELEAF has a market cap of 760.4M. Regarding current trading prices, RYLPF is priced at $23.85, while ELEAF trades at $12.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas ELEAF's P/E ratio is 10.65. In terms of profitability, RYLPF's ROE is +0.03%, compared to ELEAF's ROE of +0.15%. Regarding short-term risk, RYLPF and ELEAF have similar daily volatility (0.00).
RYLPF vs XVIPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, XVIPF has a market cap of 740.2M. Regarding current trading prices, RYLPF is priced at $23.85, while XVIPF trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas XVIPF's P/E ratio is 52.22. In terms of profitability, RYLPF's ROE is +0.03%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, RYLPF and XVIPF have similar daily volatility (0.00).
RYLPF vs CLVSF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, CLVSF has a market cap of 556.5M. Regarding current trading prices, RYLPF is priced at $23.85, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas CLVSF's P/E ratio is 38.25. In terms of profitability, RYLPF's ROE is +0.03%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, RYLPF and CLVSF have similar daily volatility (0.00).
RYLPF vs CALZF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, CALZF has a market cap of 510.3M. Regarding current trading prices, RYLPF is priced at $23.85, while CALZF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas CALZF's P/E ratio is 73.87. In terms of profitability, RYLPF's ROE is +0.03%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, RYLPF and CALZF have similar daily volatility (0.00).
RYLPF vs LBLTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, LBLTF has a market cap of 496.1M. Regarding current trading prices, RYLPF is priced at $23.85, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas LBLTF's P/E ratio is -1.22. In terms of profitability, RYLPF's ROE is +0.03%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, RYLPF and LBLTF have similar daily volatility (0.00).
RYLPF vs AVMR Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, RYLPF is priced at $23.85, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas AVMR's P/E ratio is -18.34. In terms of profitability, RYLPF's ROE is +0.03%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, RYLPF and AVMR have similar daily volatility (0.00).
RYLPF vs IOBCF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, IOBCF has a market cap of 414.5M. Regarding current trading prices, RYLPF is priced at $23.85, while IOBCF trades at $14.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas IOBCF's P/E ratio is 38.24. In terms of profitability, RYLPF's ROE is +0.03%, compared to IOBCF's ROE of +0.09%. Regarding short-term risk, RYLPF and IOBCF have similar daily volatility (0.00).
RYLPF vs HYBT Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, RYLPF is priced at $23.85, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas HYBT's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.03%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, RYLPF and HYBT have similar daily volatility (0.00).
RYLPF vs EAPIF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, EAPIF has a market cap of 347.6M. Regarding current trading prices, RYLPF is priced at $23.85, while EAPIF trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas EAPIF's P/E ratio is -2.27. In terms of profitability, RYLPF's ROE is +0.03%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, RYLPF and EAPIF have similar daily volatility (0.00).
RYLPF vs CYBQY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, CYBQY has a market cap of 328.5M. Regarding current trading prices, RYLPF is priced at $23.85, while CYBQY trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas CYBQY's P/E ratio is -69.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to CYBQY's ROE of -0.01%. Regarding short-term risk, RYLPF is less volatile compared to CYBQY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs DMTRF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, DMTRF has a market cap of 276.8M. Regarding current trading prices, RYLPF is priced at $23.85, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas DMTRF's P/E ratio is -35.86. In terms of profitability, RYLPF's ROE is +0.03%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, RYLPF and DMTRF have similar daily volatility (0.00).
RYLPF vs CSSPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, CSSPF has a market cap of 271.3M. Regarding current trading prices, RYLPF is priced at $23.85, while CSSPF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, RYLPF and CSSPF have similar daily volatility (0.00).
RYLPF vs CLLKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, CLLKF has a market cap of 255.6M. Regarding current trading prices, RYLPF is priced at $23.85, while CLLKF trades at $3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas CLLKF's P/E ratio is -8.04. In terms of profitability, RYLPF's ROE is +0.03%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, RYLPF and CLLKF have similar daily volatility (0.00).
RYLPF vs IPDQF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, IPDQF has a market cap of 248.9M. Regarding current trading prices, RYLPF is priced at $23.85, while IPDQF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas IPDQF's P/E ratio is -5.14. In terms of profitability, RYLPF's ROE is +0.03%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, RYLPF and IPDQF have similar daily volatility (0.00).
RYLPF vs HTLZF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, RYLPF is priced at $23.85, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, RYLPF's ROE is +0.03%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, RYLPF and HTLZF have similar daily volatility (0.00).
RYLPF vs BCCOY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, BCCOY has a market cap of 172.6M. Regarding current trading prices, RYLPF is priced at $23.85, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas BCCOY's P/E ratio is -5.68. In terms of profitability, RYLPF's ROE is +0.03%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, RYLPF and BCCOY have similar daily volatility (0.00).
RYLPF vs CYBQF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, CYBQF has a market cap of 163.5M. Regarding current trading prices, RYLPF is priced at $23.85, while CYBQF trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas CYBQF's P/E ratio is -61.25. In terms of profitability, RYLPF's ROE is +0.03%, compared to CYBQF's ROE of -0.01%. Regarding short-term risk, RYLPF and CYBQF have similar daily volatility (0.00).
RYLPF vs BRNHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, BRNHF has a market cap of 162.1M. Regarding current trading prices, RYLPF is priced at $23.85, while BRNHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, RYLPF's ROE is +0.03%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, RYLPF and BRNHF have similar daily volatility (0.00).
RYLPF vs EKDHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, EKDHF has a market cap of 161.7M. Regarding current trading prices, RYLPF is priced at $23.85, while EKDHF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, RYLPF and EKDHF have similar daily volatility (0.00).
RYLPF vs AVHHL Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, AVHHL has a market cap of 134.9M. Regarding current trading prices, RYLPF is priced at $23.85, while AVHHL trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas AVHHL's P/E ratio is -2.20. In terms of profitability, RYLPF's ROE is +0.03%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, RYLPF and AVHHL have similar daily volatility (0.00).
RYLPF vs PXMBF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, PXMBF has a market cap of 129M. Regarding current trading prices, RYLPF is priced at $23.85, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas PXMBF's P/E ratio is 23.33. In terms of profitability, RYLPF's ROE is +0.03%, compared to PXMBF's ROE of +0.12%. Regarding short-term risk, RYLPF and PXMBF have similar daily volatility (0.00).
RYLPF vs BRSYF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, BRSYF has a market cap of 128.5M. Regarding current trading prices, RYLPF is priced at $23.85, while BRSYF trades at $6.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, RYLPF's ROE is +0.03%, compared to BRSYF's ROE of +0.07%. Regarding short-term risk, RYLPF and BRSYF have similar daily volatility (0.00).
RYLPF vs VMTHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, VMTHF has a market cap of 125.7M. Regarding current trading prices, RYLPF is priced at $23.85, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas VMTHF's P/E ratio is -1.25. In terms of profitability, RYLPF's ROE is +0.03%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, RYLPF and VMTHF have similar daily volatility (0.00).
RYLPF vs AMEUF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, RYLPF is priced at $23.85, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, RYLPF's ROE is +0.03%, compared to AMEUF's ROE of -5.13%. Regarding short-term risk, RYLPF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs FDMDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, FDMDF has a market cap of 106.1M. Regarding current trading prices, RYLPF is priced at $23.85, while FDMDF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas FDMDF's P/E ratio is -2.85. In terms of profitability, RYLPF's ROE is +0.03%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, RYLPF and FDMDF have similar daily volatility (0.00).
RYLPF vs JMDMF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, JMDMF has a market cap of 104.4M. Regarding current trading prices, RYLPF is priced at $23.85, while JMDMF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas JMDMF's P/E ratio is -27.83. In terms of profitability, RYLPF's ROE is +0.03%, compared to JMDMF's ROE of N/A. Regarding short-term risk, RYLPF and JMDMF have similar daily volatility (0.00).
RYLPF vs IMPZY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, IMPZY has a market cap of 100M. Regarding current trading prices, RYLPF is priced at $23.85, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas IMPZY's P/E ratio is -0.80. In terms of profitability, RYLPF's ROE is +0.03%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, RYLPF and IMPZY have similar daily volatility (0.00).
RYLPF vs SOMNF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, SOMNF has a market cap of 92.1M. Regarding current trading prices, RYLPF is priced at $23.85, while SOMNF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas SOMNF's P/E ratio is -14.20. In terms of profitability, RYLPF's ROE is +0.03%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, RYLPF and SOMNF have similar daily volatility (0.00).
RYLPF vs RSHUF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, RYLPF is priced at $23.85, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, RYLPF's ROE is +0.03%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, RYLPF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SNZZF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, SNZZF has a market cap of 86.5M. Regarding current trading prices, RYLPF is priced at $23.85, while SNZZF trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas SNZZF's P/E ratio is -5.50. In terms of profitability, RYLPF's ROE is +0.03%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, RYLPF and SNZZF have similar daily volatility (0.00).
RYLPF vs CKMTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, RYLPF is priced at $23.85, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, RYLPF's ROE is +0.03%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, RYLPF and CKMTF have similar daily volatility (0.00).
RYLPF vs RDGL Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, RDGL has a market cap of 62.5M. Regarding current trading prices, RYLPF is priced at $23.85, while RDGL trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas RDGL's P/E ratio is -13.78. In terms of profitability, RYLPF's ROE is +0.03%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, RYLPF is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs BLOZF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, BLOZF has a market cap of 50.5M. Regarding current trading prices, RYLPF is priced at $23.85, while BLOZF trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas BLOZF's P/E ratio is -21.91. In terms of profitability, RYLPF's ROE is +0.03%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, RYLPF is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CRRVF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, CRRVF has a market cap of 46.3M. Regarding current trading prices, RYLPF is priced at $23.85, while CRRVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas CRRVF's P/E ratio is -0.01. In terms of profitability, RYLPF's ROE is +0.03%, compared to CRRVF's ROE of +0.00%. Regarding short-term risk, RYLPF and CRRVF have similar daily volatility (0.00).
RYLPF vs NVYTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, NVYTF has a market cap of 38.1M. Regarding current trading prices, RYLPF is priced at $23.85, while NVYTF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas NVYTF's P/E ratio is -0.72. In terms of profitability, RYLPF's ROE is +0.03%, compared to NVYTF's ROE of +0.00%. Regarding short-term risk, RYLPF and NVYTF have similar daily volatility (0.00).
RYLPF vs TLTFF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, TLTFF has a market cap of 37.2M. Regarding current trading prices, RYLPF is priced at $23.85, while TLTFF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas TLTFF's P/E ratio is -14.82. In terms of profitability, RYLPF's ROE is +0.03%, compared to TLTFF's ROE of -2.57%. Regarding short-term risk, RYLPF and TLTFF have similar daily volatility (0.00).
RYLPF vs ELXMF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, ELXMF has a market cap of 28.4M. Regarding current trading prices, RYLPF is priced at $23.85, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, RYLPF and ELXMF have similar daily volatility (0.00).
RYLPF vs MKEAF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, RYLPF is priced at $23.85, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, RYLPF's ROE is +0.03%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, RYLPF and MKEAF have similar daily volatility (0.00).
RYLPF vs PLLWF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, PLLWF has a market cap of 24.1M. Regarding current trading prices, RYLPF is priced at $23.85, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas PLLWF's P/E ratio is -2.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to PLLWF's ROE of -0.61%. Regarding short-term risk, RYLPF and PLLWF have similar daily volatility (0.00).
RYLPF vs KBBTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, RYLPF is priced at $23.85, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, RYLPF's ROE is +0.03%, compared to KBBTF's ROE of N/A. Regarding short-term risk, RYLPF and KBBTF have similar daily volatility (0.00).
RYLPF vs POSC Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, POSC has a market cap of 21.6M. Regarding current trading prices, RYLPF is priced at $23.85, while POSC trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas POSC's P/E ratio is 0.37. In terms of profitability, RYLPF's ROE is +0.03%, compared to POSC's ROE of +9.25%. Regarding short-term risk, RYLPF is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs MDXHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, MDXHF has a market cap of 19.8M. Regarding current trading prices, RYLPF is priced at $23.85, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, RYLPF's ROE is +0.03%, compared to MDXHF's ROE of +0.49%. Regarding short-term risk, RYLPF and MDXHF have similar daily volatility (0.00).
RYLPF vs ASAPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, ASAPF has a market cap of 19.5M. Regarding current trading prices, RYLPF is priced at $23.85, while ASAPF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas ASAPF's P/E ratio is -24.98. In terms of profitability, RYLPF's ROE is +0.03%, compared to ASAPF's ROE of -0.23%. Regarding short-term risk, RYLPF is less volatile compared to ASAPF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs EMITF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, EMITF has a market cap of 19.4M. Regarding current trading prices, RYLPF is priced at $23.85, while EMITF trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas EMITF's P/E ratio is -11.67. In terms of profitability, RYLPF's ROE is +0.03%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, RYLPF and EMITF have similar daily volatility (0.00).
RYLPF vs PYNKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, PYNKF has a market cap of 18.9M. Regarding current trading prices, RYLPF is priced at $23.85, while PYNKF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas PYNKF's P/E ratio is -0.91. In terms of profitability, RYLPF's ROE is +0.03%, compared to PYNKF's ROE of -1.58%. Regarding short-term risk, RYLPF and PYNKF have similar daily volatility (0.00).
RYLPF vs GTHP Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, GTHP has a market cap of 18.5M. Regarding current trading prices, RYLPF is priced at $23.85, while GTHP trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas GTHP's P/E ratio is -4.70. In terms of profitability, RYLPF's ROE is +0.03%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, RYLPF is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs DIZTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, RYLPF is priced at $23.85, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, RYLPF's ROE is +0.03%, compared to DIZTF's ROE of -2.22%. Regarding short-term risk, RYLPF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs VPTDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, VPTDF has a market cap of 18M. Regarding current trading prices, RYLPF is priced at $23.85, while VPTDF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas VPTDF's P/E ratio is -5.39. In terms of profitability, RYLPF's ROE is +0.03%, compared to VPTDF's ROE of +1.70%. Regarding short-term risk, RYLPF is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs TMDIF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, RYLPF is priced at $23.85, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, RYLPF's ROE is +0.03%, compared to TMDIF's ROE of -1.38%. Regarding short-term risk, RYLPF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs RMSL Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, RMSL has a market cap of 12.5M. Regarding current trading prices, RYLPF is priced at $23.85, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas RMSL's P/E ratio is 0.82. In terms of profitability, RYLPF's ROE is +0.03%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, RYLPF is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs ZMSPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, ZMSPF has a market cap of 12.3M. Regarding current trading prices, RYLPF is priced at $23.85, while ZMSPF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas ZMSPF's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.03%, compared to ZMSPF's ROE of +0.82%. Regarding short-term risk, RYLPF and ZMSPF have similar daily volatility (0.00).
RYLPF vs ATBPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, RYLPF is priced at $23.85, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, RYLPF's ROE is +0.03%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, RYLPF is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs LXXGF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, RYLPF is priced at $23.85, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, RYLPF's ROE is +0.03%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, RYLPF and LXXGF have similar daily volatility (0.00).
RYLPF vs NGMDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, NGMDF has a market cap of 8.5M. Regarding current trading prices, RYLPF is priced at $23.85, while NGMDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas NGMDF's P/E ratio is -3.74. In terms of profitability, RYLPF's ROE is +0.03%, compared to NGMDF's ROE of +0.36%. Regarding short-term risk, RYLPF and NGMDF have similar daily volatility (0.00).
RYLPF vs FZMD Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, FZMD has a market cap of 7.4M. Regarding current trading prices, RYLPF is priced at $23.85, while FZMD trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas FZMD's P/E ratio is 2.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, RYLPF and FZMD have similar daily volatility (0.00).
RYLPF vs DTXMF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, DTXMF has a market cap of 5.7M. Regarding current trading prices, RYLPF is priced at $23.85, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, RYLPF's ROE is +0.03%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, RYLPF and DTXMF have similar daily volatility (0.00).
RYLPF vs QLIS Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, RYLPF is priced at $23.85, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas QLIS's P/E ratio is 2.22. In terms of profitability, RYLPF's ROE is +0.03%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, RYLPF and QLIS have similar daily volatility (0.00).
RYLPF vs RHNMF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, RYLPF is priced at $23.85, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, RYLPF's ROE is +0.03%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, RYLPF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs NUMD Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, NUMD has a market cap of 4.2M. Regarding current trading prices, RYLPF is priced at $23.85, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas NUMD's P/E ratio is 5.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, RYLPF and NUMD have similar daily volatility (0.00).
RYLPF vs ADMT Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, ADMT has a market cap of 4M. Regarding current trading prices, RYLPF is priced at $23.85, while ADMT trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas ADMT's P/E ratio is -5.97. In terms of profitability, RYLPF's ROE is +0.03%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, RYLPF is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs BIEL Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, BIEL has a market cap of 3.6M. Regarding current trading prices, RYLPF is priced at $23.85, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas BIEL's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.03%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, RYLPF and BIEL have similar daily volatility (0.00).
RYLPF vs ALRTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, ALRTF has a market cap of 3.5M. Regarding current trading prices, RYLPF is priced at $23.85, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas ALRTF's P/E ratio is -0.18. In terms of profitability, RYLPF's ROE is +0.03%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, RYLPF is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs TBRIF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, TBRIF has a market cap of 3.4M. Regarding current trading prices, RYLPF is priced at $23.85, while TBRIF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas TBRIF's P/E ratio is -0.91. In terms of profitability, RYLPF's ROE is +0.03%, compared to TBRIF's ROE of -2.28%. Regarding short-term risk, RYLPF is less volatile compared to TBRIF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs VANIW Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, RYLPF is priced at $23.85, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas VANIW's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.03%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, RYLPF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs VYCO Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, VYCO has a market cap of 3.3M. Regarding current trading prices, RYLPF is priced at $23.85, while VYCO trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas VYCO's P/E ratio is -10.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, RYLPF is less volatile compared to VYCO. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs ESMC Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, ESMC has a market cap of 2.4M. Regarding current trading prices, RYLPF is priced at $23.85, while ESMC trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas ESMC's P/E ratio is 6.50. In terms of profitability, RYLPF's ROE is +0.03%, compared to ESMC's ROE of +0.00%. Regarding short-term risk, RYLPF is less volatile compared to ESMC. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs PMEDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, PMEDF has a market cap of 2.1M. Regarding current trading prices, RYLPF is priced at $23.85, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas PMEDF's P/E ratio is -1.11. In terms of profitability, RYLPF's ROE is +0.03%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, RYLPF and PMEDF have similar daily volatility (0.00).
RYLPF vs USAQ Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, USAQ has a market cap of 2M. Regarding current trading prices, RYLPF is priced at $23.85, while USAQ trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas USAQ's P/E ratio is -4.50. In terms of profitability, RYLPF's ROE is +0.03%, compared to USAQ's ROE of +0.67%. Regarding short-term risk, RYLPF and USAQ have similar daily volatility (0.00).
RYLPF vs MSIU Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, MSIU has a market cap of 1.9M. Regarding current trading prices, RYLPF is priced at $23.85, while MSIU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas MSIU's P/E ratio is -2.19. In terms of profitability, RYLPF's ROE is +0.03%, compared to MSIU's ROE of -3.07%. Regarding short-term risk, RYLPF and MSIU have similar daily volatility (0.00).
RYLPF vs BRSF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.8B. In comparison, BRSF has a market cap of 1.7M. Regarding current trading prices, RYLPF is priced at $23.85, while BRSF trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.42, whereas BRSF's P/E ratio is -0.11. In terms of profitability, RYLPF's ROE is +0.03%, compared to BRSF's ROE of -6.82%. Regarding short-term risk, RYLPF and BRSF have similar daily volatility (0.00).